Ati cautat: medicamente de baza
CDC si FDA au autorizat utilizarea vaccinului anti-Covid Novavax in randul adolescentilor
Protocol terapeutic: A16AX16 – GIVOSIRAN (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)
Protocol terapeutic: A16AX09 – GLYCEROLI PHENYLBUTYRAS (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)
Protocol terapeutic: R07AX02 – DCI IVACAFTORUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L02BB05 – DCI APALUTAMIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XX71 – DCI TISAGENLECLEUCEL (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XX24 – DCI PEGASPARGASUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: J05AX18 – DCI LETERMOVIRUM (forma orală) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: DCI FOLLITROPINUM ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: D11AH05 – DCI DUPILUMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
